Kynam Capital Management, LP Q3 2025 Filing

Filed November 14, 2025

Portfolio Value

$1.3T

Holdings

35

Report Date

Q3 2025

Filing Type

13F-HR

All Holdings (35 positions)

#StockSharesValue% PortfolioType
1
TCE2CELLDEX THERAPEUTICS INC NEW
6,100,729$157.8B11.75%
2
SNDXSYNDAX PHARMACEUTICALS INC
8,520,000$131.1B9.76%
3
VERAVERA THERAPEUTICS INC
4,027,800$117.0B8.71%
4
COGTCOGENT BIOSCIENCES INC
7,886,172$113.2B8.43%
5
PCVXVAXCYTE INC
3,071,588$110.6B8.24%
6
VRDNVIRIDIAN THERAPEUTICS INC
4,427,927$95.6B7.11%
7
CGONCG ONCOLOGY INC
2,005,205$80.8B6.01%
8
BCRXBIOCRYST PHARMACEUTICALS INC
9,390,270$71.3B5.31%
9
BEAMBEAM THERAPEUTICS INC
2,517,647$61.1B4.55%
10
IMCRIMMUNOCORE HLDGS PLC
1,009,267$36.7B2.73%
11
MBXMBX BIOSCIENCES INC
2,000,000$35.0B2.61%
12
ENGNENGENE HOLDINGS INC
4,994,090$34.1B2.54%
13
WVEWAVE LIFE SCIENCES LTD
4,560,053$33.4B2.49%
14
TYRATYRA BIOSCIENCES INC
2,329,998$32.6B2.43%
15
TVTXTRAVERE THERAPEUTICS INC
949,727$22.7B1.69%
16
DVAXDYNAVAX TECHNOLOGIES CORP
2,145,319$21.3B1.59%
17
NRIXNURIX THERAPEUTICS INC
2,168,605$20.0B1.49%
18
UTHUNITED THERAPEUTICS CORP DEL
67,588$20.0B1.49%
19
APLSAPELLIS PHARMACEUTICALS INC
808,607$18.3B1.36%
20
PHVSPHARVARIS N V
675,000$16.8B1.25%
21
RLAYRELAY THERAPEUTICS INC
2,887,014$15.1B1.12%
22
CGEMCULLINAN THERAPEUTICS INC
2,302,172$13.7B1.02%
23
CTMXCYTOMX THERAPEUTICS INC
3,646,503$11.6B0.87%
24
EH3AMARIN CORP PLC
576,111$9.4B0.70%
25
BNRBURNING ROCK BIOTECH LTD
994,883$8.6B0.64%
26
DSGNDESIGN THERAPEUTICS INC
1,029,579$7.8B0.58%
27
KALVKALVISTA PHARMACEUTICALS INC
606,171$7.4B0.55%
28
IRWDIRONWOOD PHARMACEUTICALS INC
5,466,825$7.2B0.53%
29
CRBUCARIBOU BIOSCIENCES INC
3,067,774$7.1B0.53%
30
URGNUROGEN PHARMA LTD
282,412$6.9B0.52%
31
GONGERON CORP
3,456,318$4.7B0.35%
32
STROSUTRO BIOPHARMA INC
5,088,099$4.4B0.33%
33
EWTXEDGEWISE THERAPEUTICS INC
253,979$4.1B0.31%
34
PRQRPROQR THRAPEUTICS N V
1,649,462$3.5B0.26%
35
CLYMCLIMB BIO INC
1,028,341$2.1B0.15%